{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:30:57Z","timestamp":1787135457115,"version":"build-2736575974"},"reference-count":53,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Hainan Province Clinical Medical Center, and the Science and Technology Planning Project of Hainan Province","award":["LCYX2024-06"],"award-info":[{"award-number":["LCYX2024-06"]}]},{"name":"Hainan Province Clinical Medical Center, and the Science and Technology Planning Project of Hainan Province","award":["ZDYF2022SHFZ326"],"award-info":[{"award-number":["ZDYF2022SHFZ326"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82271116"],"award-info":[{"award-number":["82271116"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2026,1,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>This study aims to evaluate the effects of brimonidine eye drops and intravitreal administration in guinea pigs with form-deprivation myopia (FDM) and to analyze the ocular pharmacokinetics and irritation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The experimental guinea pigs were randomized to the normal control, FDM, FDM brimonidine topical eye drops, and FDM intravitreal injection groups. The experiment period was 13 days. Changes in ocular refraction and axial length were monitored regularly. The ocular pharmacokinetics of brimonidine and its metabolite brimonidine-2,3-dione were analyzed using ultra-performance liquid chromatography-tandem mass spectrometry. Ocular irritation was assessed by the Draize test, corneal fluorescein staining, and hematoxylin and eosin staining.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Two administration methods of brimonidine equally inhibited the increase in refraction and axial length in FDM guinea pigs (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.05). Pharmacokinetic analysis revealed significant and sustained accumulation of brimonidine in the iris and choroid. Brimonidine was preferentially distributed to the cornea, conjunctiva, and sclera when administered topically, and preferentially to the retina and vitreous when administered intravitreally. The total area under the curve values for retinal and scleral tissues demonstrated that continuous topical administration was 1.95 times and 1.36 times that of intravitreal administration, respectively. The concentration of brimonidine-2,3-dione was significantly lower than that of brimonidine. Brimonidine topical eyedrops had less ocular irritation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>At the drug concentrations in this study, both topical and intravitreal brimonidine achieved sufficient ocular exposure to exert similar myopia-suppressing effects. Continuous topical administration can maintain higher drug concentrations in the retinal and scleral tissues with less eye irritation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10807683251376438","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T16:55:01Z","timestamp":1758214501000},"page":"63-73","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Brimonidine Topical Eye Drops and Intravitreal Administration Inhibit Form-Deprivation Myopia in Guinea Pigs: Ocular Pharmacokinetics and Irritation"],"prefix":"10.1177","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9437-6273","authenticated-orcid":false,"given":"Fang","family":"Zeng","sequence":"first","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"He","sequence":"additional","affiliation":[{"name":"Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Haikou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengai","family":"Huang","sequence":"additional","affiliation":[{"name":"Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Haikou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Luo","sequence":"additional","affiliation":[{"name":"Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Haikou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junming","family":"Yang","sequence":"additional","affiliation":[{"name":"Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Haikou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwu","family":"Zhong","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China."},{"name":"Hainan Eye Hospital and Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Haikou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-7538-4120","authenticated-orcid":false,"given":"Guofu","family":"Huang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangzhou, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"e_1_3_5_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/519276a"},{"key":"e_1_3_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2016.01.006"},{"key":"e_1_3_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2018.10.005"},{"key":"e_1_3_5_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2018-313798"},{"issue":"12","key":"e_1_3_5_6_2","first-page":"2849","article-title":"Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension","volume":"42","author":"WoldeMussie E","year":"2001","unstructured":"WoldeMussie E, , Ruiz G, , Wijono M, et al. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Visual Sci, 2001; 42(12):2849\u20132855.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_5_7_2","first-page":"785","article-title":"\u03b1-adrenergic agonist brimonidine control of experimentally induced myopia in guinea pigs: A pilot study","volume":"23","author":"Liu Y","year":"2017","unstructured":"Liu Y, , Wang Y, , Lv H, et al. \u03b1-adrenergic agonist brimonidine control of experimentally induced myopia in guinea pigs: A pilot study. Mol Vision, 2017; 23:785\u2013798.","journal-title":"Mol Vision"},{"key":"e_1_3_5_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/cxo.12871"},{"key":"e_1_3_5_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37416"},{"key":"e_1_3_5_10_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40662-021-00248-0"},{"key":"e_1_3_5_11_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.17-22562"},{"key":"e_1_3_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121361"},{"key":"e_1_3_5_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6257(01)00211-9"},{"key":"e_1_3_5_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200310000-00008"},{"key":"e_1_3_5_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-024-03433-6"},{"key":"e_1_3_5_16_2","doi-asserted-by":"publisher","DOI":"10.2174\/1389200033489488"},{"key":"e_1_3_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2015.10.009"},{"issue":"5","key":"e_1_3_5_18_2","first-page":"961","article-title":"Drug delivery for posterior segment eye disease","volume":"41","author":"Geroski DH","year":"2000","unstructured":"Geroski DH, , Edelhauser HF. Drug delivery for posterior segment eye disease. Invest Ophthalmol Visual Sci, 2000; 41(5):961\u2013964.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120332"},{"key":"e_1_3_5_20_2","doi-asserted-by":"publisher","DOI":"10.1533\/9781908818317.1"},{"key":"e_1_3_5_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061150"},{"key":"e_1_3_5_22_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.61.12.4"},{"key":"e_1_3_5_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-019-04573-y"},{"key":"e_1_3_5_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15629"},{"key":"e_1_3_5_25_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.01281.2005"},{"key":"e_1_3_5_26_2","doi-asserted-by":"publisher","DOI":"10.1006\/exer.1994.1049"},{"key":"e_1_3_5_27_2","doi-asserted-by":"publisher","DOI":"10.1017\/S0952523802191152"},{"issue":"6","key":"e_1_3_5_28_2","first-page":"1183","article-title":"Expression of bFGF and TGF-beta 2 in experimental myopia in chicks","volume":"36","author":"Seko Y","year":"1995","unstructured":"Seko Y, , Shimokawa H, , Tokoro T. Expression of bFGF and TGF-beta 2 in experimental myopia in chicks. Invest Ophthalmol Visual Sci, 1995; 36(6):1183\u20131187.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_5_29_2","doi-asserted-by":"publisher","DOI":"10.1006\/exer.2001.1064"},{"key":"e_1_3_5_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.111092"},{"issue":"3","key":"e_1_3_5_31_2","first-page":"627","article-title":"Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera","volume":"38","author":"H\u00e4m\u00e4l\u00e4inen KM","year":"1997","unstructured":"H\u00e4m\u00e4l\u00e4inen KM, , Kananen K, , Auriola S, et al. Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. Invest Ophthalmol Visual Sci, 1997; 38(3):627\u2013634.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_5_32_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1012123411343"},{"key":"e_1_3_5_33_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2023.0038"},{"key":"e_1_3_5_34_2","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.30.4.421"},{"key":"e_1_3_5_35_2","doi-asserted-by":"publisher","DOI":"10.3109\/02713689008997579"},{"key":"e_1_3_5_36_2","doi-asserted-by":"publisher","DOI":"10.1177\/2472555217724780"},{"issue":"4","key":"e_1_3_5_37_2","first-page":"584","article-title":"Importance of the noncorneal absorption route in topical ophthalmic drug delivery","volume":"26","author":"Ahmed I","year":"1985","unstructured":"Ahmed I, , Patton TF. Importance of the noncorneal absorption route in topical ophthalmic drug delivery. Invest Ophthalmol Visual Sci, 1985; 26(4):584\u2013587.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_5_38_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-74901-3_13"},{"key":"e_1_3_5_39_2","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics12030269"},{"key":"e_1_3_5_40_2","doi-asserted-by":"publisher","DOI":"10.3390\/ph17121579"},{"key":"e_1_3_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2017.09.008"},{"key":"e_1_3_5_42_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2023.0020"},{"key":"e_1_3_5_43_2","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2016.1238941"},{"key":"e_1_3_5_44_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.120.000483"},{"key":"e_1_3_5_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-9556(25)06647-4"},{"key":"e_1_3_5_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14024"},{"key":"e_1_3_5_47_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.65.12.14"},{"key":"e_1_3_5_48_2","doi-asserted-by":"publisher","DOI":"10.1021\/acs.molpharmaceut.4c00694"},{"key":"e_1_3_5_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38056-w"},{"issue":"7","key":"e_1_3_5_50_2","first-page":"1204","article-title":"Nicotinamide N-oxide reductase activity in bovine and rabbit eyes","volume":"28","author":"Shimada S","year":"1987","unstructured":"Shimada S, , Mishima H, , Kitamura S, et al. Nicotinamide N-oxide reductase activity in bovine and rabbit eyes. Invest Ophthalmol Visual Sci, 1987; 28(7):1204\u20131206.","journal-title":"Invest Ophthalmol Visual Sci"},{"key":"e_1_3_5_51_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13144158"},{"key":"e_1_3_5_52_2","doi-asserted-by":"publisher","DOI":"10.1067\/mpa.2001.117571"},{"key":"e_1_3_5_53_2","doi-asserted-by":"publisher","DOI":"10.2165\/00148581-200709020-00001"},{"key":"e_1_3_5_54_2","doi-asserted-by":"publisher","DOI":"10.1177\/0960327120918307"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10807683251376438","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683251376438","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10807683251376438","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T10:21:22Z","timestamp":1787134882000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10807683251376438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,1]]}},"alternative-id":["10.1177\/10807683251376438"],"URL":"https:\/\/doi.org\/10.1177\/10807683251376438","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]}}}